AGMB vs SOLV: fair value comparison
AgomAb Therapeutics NV and Solventum Corporation · Updated 2026-10-19
AGMB reports in EUR, so no same-currency fair-value verdict is published for it. Within Healthcare, SOLV currently ranks higher by quality score.
| AGMB | SOLV | |
|---|---|---|
| Verdict | Awaiting full valuation | Fairly valued |
| Last price | $8.65 | $87.29 |
| 12-month range | $8.65–$16.21 | $62.49–$92.44 |
| Rank by discount to fair value | — | #63 of 108 Healthcare |
| Rank by quality score | #216 of 301 Healthcare | #214 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Moderate |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Oversold | Neutral |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: AGMB fair value analysis · SOLV fair value analysis